A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China

CompletedOBSERVATIONAL
Enrollment

1,490

Participants

Timeline

Start Date

July 9, 2020

Primary Completion Date

July 8, 2024

Study Completion Date

April 7, 2025

Conditions
NSCLC, Stage INSCLC, Stage IINSCLC, Stage III
Interventions
PROCEDURE

Surgeries

Surgeries

Trial Locations (51)

24000

Affiliated Hospital of Chifeng University, Chifeng

50000

The Fourth Hospital of Hebei Medical University, Shijiazhuang

100000

Beijing Cancer Hospital, Beijing

Beijing Chest Hospital,Capital Medical university, Beijing

Peking Union Medical College Hospital, Beijing

Peking University People'S Hospital, Beijing

Peking University Third Hospital, Beijing

Xuanwu Hospital Capital Medical University, Beijing

110000

Shengjing Hospital of China Medical University, Shenyang

The First Hospital of China Medical University, Shenyang

116000

The Second Hospital of Dalian Medical University, Dalian

130000

Bethune first hospital of jilin university, Changchun

China-Japan Union Hospital of JiLin University, Changchun

200000

Shanghai Jiaotong University Medical College Affiliated Ruijin hospital, Shanghai

Shanghai Jiaotong University School of Medicine, Shanghai

ZhongShan Hospital, Shanghai

210000

Jiangsu Province Hospital, Nanjing

215000

Suzhou Municipal Hospital, Suzhou

The First Affiliated Hospital of Soochow University, Suzhou

250000

Qilu Hospital of Shandong Yniversity, Jinan

Shandong Cancer Hospital, Jinan

255000

PKUCare Luzhong Hospital, Zibo

300000

Tianjin Chest Hospital, Tianjin

Tianjin Medical University General Hospital, Tianjin

310000

Sir Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou

The first affiliated hospital zhejiang university, Hangzhou

The Second Affiliated hospital of Zhejiang University Achool of Medical, Hangzhou

Zhejiang cancer hospital, Hangzhou

312000

Shaoxing People's Hospital, Shaoxing

315000

Ningbo Medical Center Lihuili Hospital, Ningbo

318000

Taizhou Hospita of Zhejiang Province, Taizhou

330000

The First Affiliated Hospital of Nanchang University, Nanchang

The Second Affiliated Hospital Of Nanchang University, Nanchang

350000

Fujian Provincial Hospital, Fuzhou

400000

Chongqing Cancer Hospital, Chongqing

410000

Xiangya Hospital Central South University, Changsha

430000

Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan

450000

Henan Provincial People's Hospital, Zhengzhou

455000

Anyang Tumour Hospital, Anyang

510000

Cancer Center of Guangzhou Medical university, Guangzhou

Guangdong Provincial People's Hospital, Guangzhou

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

The First Affiliated Hospital,Sun Yat-sen University, Guangzhou

518000

Shenzhen People's Hospital, Shenzhen

524000

Affiliated Hospital of Guangdong Medical University, Zhanjiang

530000

The second affiliated hospital of guangxi medical university, Nanning

610000

West China Hospital of Sichuan University, Chengdu

646000

The Affliated of Southwest Medical University, Luzhou

061000

Cangzhou Central Hospital, Cangzhou

010000

The Affliated of Inner Mongolia Medical University, Hohhot

030000

Shanxi Provincial Cancer Hospital, Taiyuan

All Listed Sponsors
lead

The First Affiliated Hospital of Guangzhou Medical University

OTHER

NCT04830826 - A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China | Biotech Hunter | Biotech Hunter